INS and Hyperglycemia: Although hyperglycemia-induced metabolic abnormalities including polyol-pathway hyperactivity, oxidative stress, protein kinase C alteration and advanced glycation end-products contribute to type 1 DPN [3, 4], impaired insulin/C-peptide signaling has emerged as an additional initiating and important factor in its pathogenesis [2, 5].